Paul Weiss, Venture Investors

Paul Weiss is a Managing Director at Venture Investors Health Fund in Madison, Wisconsin. See sector focus and contact routes.

About Paul Weiss

Paul Weiss is a Managing Director at Venture Investors Health Fund in Madison, Wisconsin, having joined the firm in 2006 with over 20 years of operating experience in biotech and pharmaceuticals. His investment thesis targets biopharma, diagnostics, and devices with biopharma overlap, focusing on seed and early-stage healthcare companies primarily in the Midwest region. While specific check sizes and lead/follow behavior are not publicly detailed, he actively serves on the boards of multiple portfolio companies including Invenra, Iterion Therapeutics, FluGen, and Madison Vaccines. His notable portfolio also includes Neurovance, which was sold to Otsuka for up to $1 billion, and Aerpio Pharmaceuticals, now Aadi Bioscience. Weiss leverages his prior executive roles at Cardinal Health, 3-Dimensional Pharmaceuticals, and Wyeth-Ayerst to evaluate investment prospects. No distinctive public writing or unique point of view beyond his operational focus is documented in available sources.

Paul Weiss at a glance

Role
Managing Director
Organization
Venture Investors
Location
Madison, Wisconsin
Investor type
Venture Capital
Focus areas
Banking, Finance, Venture Capital, Biotechnology, Health Care, Medical, Medical Device, Therapeutics

Frequently asked about Paul Weiss

What does Paul Weiss invest in?
Paul Weiss at Venture Investors (Madison, Wisconsin) — sector focus: Banking, Finance, Venture Capital, Biotechnology, Health Care, Medical, Medical Device, Therapeutics, Pharmaceutical, Life Science, Software, Health Diagnostic….
How do I contact Paul Weiss?
Paul Weiss's published profile links (website, LinkedIn or X where available) are listed on the StartupFundraising.com investor profile.
Where is Paul Weiss based?
Paul Weiss is based in Madison, Wisconsin.

Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Madison when building a target list.

Investors similar to Paul Weiss (20)

Browse related investor lists (1)

Compare Paul Weiss (8)

Investors like Paul Weiss · Full investor directory · Investor access · Company funding database

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades